Mydecine Innovations

(OTC: MYCOF)
0.41 -0.0148 -3.52%
Stock Price | Jan. 26, 2021, 12:34 p.m.
0 Followers
Bid: 0.406
Ask: 0.4149
Prev. Close: 0.4208
52 Week Low: 0.1257
52 Week High: 0.578
PE Ratio:
Dividend Yield: %

Company Summary

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

Read more Read less

Recently Viewed Tickers

7 months ago